SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-004149
Filing Date
2024-02-14
Accepted
2024-02-14 16:05:58
Documents
96
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q aytu20231231_10q.htm   iXBRL 10-Q 1288809
2 EXHIBIT 10.1 ex_626088.htm EX-10.1 211464
3 EXHIBIT 31.1 ex_612117.htm EX-31.1 13435
4 EXHIBIT 31.2 ex_612118.htm EX-31.2 13713
5 EXHIBIT 32.1 ex_612119.htm EX-32.1 8424
11 aytu20231231_10qimg001.jpg GRAPHIC 2569
  Complete submission text file 0001437749-24-004149.txt   8155788

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aytu-20231231.xsd EX-101.SCH 77970
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aytu-20231231_cal.xml EX-101.CAL 60303
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aytu-20231231_def.xml EX-101.DEF 549305
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20231231_lab.xml EX-101.LAB 426030
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20231231_pre.xml EX-101.PRE 589860
98 EXTRACTED XBRL INSTANCE DOCUMENT aytu20231231_10q_htm.xml XML 1340729
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38247 | Film No.: 24637843
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)